Pricing Log in Create free account

NovaBridge Biosciences (NBP) vs Protara Therapeutics, Inc. (TARA)

NovaBridge Biosciences and Protara Therapeutics, Inc. are both Biotechnology companies. NovaBridge Biosciences and Protara Therapeutics, Inc. are of similar size ($149.6M and $141.8M). Across the 10 metrics below, NovaBridge Biosciences leads on 7 and Protara Therapeutics, Inc. on 3.

Valuation

Metric NBP TARA Biotechnology median
P/E n/m n/m 8.50
P/S 5.31 n/m 9.71
P/B 0.51 0.88 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA 1.94 n/m 0.64
EV/Sales (3.81) n/m 9.21
Earnings yield (38.61%) (57.94%) (33.15%)
Free cash flow yield (89.83%) (46.79%) (25.50%)

Profitability

Metric NBP TARA Biotechnology median
Gross margin 31.10% 0.00% 65.16%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity 0.00% (45.80%) (56.36%)
Return on assets 0.00% (42.05%) (48.04%)
Return on invested capital 0.00% (255.06%) 0.00%

Growth

Metric NBP TARA Biotechnology median
Revenue growth (TTM) (91.84%) — 6.02%
EPS growth (last fiscal year) (77.78%) 38.25% 30.26%
Revenue growth, 5-year CAGR (40.00%) — 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric NBP TARA Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 7.64 10.97 4.72
Net debt to EBITDA 2.26 2.38 0.96

Dividend

Metric NBP TARA Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric NBP TARA Biotechnology median
Market cap 149.64m 141.83m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack